Class notes
Notities klinische biologische psychologie 2023 1MA VUB
- Course
- Institution
Dit zijn notities van de lessen klinische biologische psychologie. Na elke les wordt het meest recente document upgeload. Veel succes!
[Show more]
Seller
Follow
studentsammie
Reviews received
Content preview
1KLINISCHE BIOLOGISCHE PSYCHOLOGIE
INHOUD
Introductie ....................................................................................................................................................... 6
Onderwijsteam .................................................................................................................................................... 6
Doelstellingen + situering .................................................................................................................................... 6
Hoorcolleges ....................................................................................................................................................... 6
Evaluatie .............................................................................................................................................................. 6
WPO’s .................................................................................................................................................................. 7
Evaluatie .......................................................................................................................................................... 7
Voorbereiding ................................................................................................................................................. 7
Topics: subklinische populaties ....................................................................................................................... 8
Onderwerpen literatuuroverzicht ................................................................................................................... 8
Keuze onderwerp ............................................................................................................................................ 8
Opstellen onderzoeksvraag ............................................................................................................................. 9
Literatuuroverzicht .......................................................................................................................................... 9
Abstract ......................................................................................................................................................... 10
Presentatie .................................................................................................................................................... 10
Deadlines ....................................................................................................................................................... 10
Evaluatie ........................................................................................................................................................ 10
Neurobiologische perspectieven op autisme .................................................................................................. 11
Inhoud ............................................................................................................................................................... 11
Wat is autisme? ................................................................................................................................................. 11
DSM-V ........................................................................................................................................................... 11
Cognitieve theorieën ......................................................................................................................................... 11
Theory of Mind Baron-Cohen et al., 1990 ..................................................................................................... 11
Executief Dysfunctioneren Pennington & Ozonoff, 1996 ............................................................................. 12
Centrale Coherentie Frith, 1989 .................................................................................................................... 12
Neuro-ontwikkeling........................................................................................................................................... 12
Early Brain Overgrowth Theory (Courchesne et al., 2007) ............................................................................ 12
Over-pruning hypothesis (Thomas et al., 2016) ............................................................................................ 13
Excitatie-inhibitie Imbalans (Rubenstein & Merzenich, 2003) ...................................................................... 13
Primitive Brain Dysfunction Hypothesis (Jure, 2022) .................................................................................... 13
Belangrijke hersennetwerken ........................................................................................................................... 14
Saillantienetwerk .......................................................................................................................................... 14
Default Mode Network (DMN) ...................................................................................................................... 14
Central Executive Network (CEN) .................................................................................................................. 14
, 2
Samenspel! Hersenorkest ............................................................................................................................. 14
4e grote speler = Het Voorspellende Brein ................................................................................................... 15
Cerebellum: Functies .................................................................................................................................... 15
Anatomisch (structureel) Fatemi et al., 2012 ................................................................................................ 15
Neurobiologisch Fatemi et al., 2012 ............................................................................................................. 16
Connectiviteit ................................................................................................................................................ 16
Cerebello-cerebrale connecties .................................................................................................................... 16
Ontwikkeling ................................................................................................................................................. 16
Neurobiologische Theorieën (en het cerebellum) ............................................................................................. 17
Saillantie ........................................................................................................................................................ 17
Predictie ........................................................................................................................................................ 18
Integratief Kader ............................................................................................................................................... 20
Klinische Toepassingen?.................................................................................................................................... 20
Diagnostisch .................................................................................................................................................. 20
Interventies/ therapie Medicatie? .................................................................................................................... 22
Medicatie? .................................................................................................................................................... 22
Neurostimulatie ............................................................................................................................................ 22
Neurowetenschappelijke interventies .......................................................................................................... 23
Over het algemeen ........................................................................................................................................ 23
Psycho-educatie ............................................................................................................................................ 23
De ziekte van parkinson & gerelateerde stoornissen ...................................................................................... 24
Lesinhoud .......................................................................................................................................................... 24
Hersengebieden en functies ............................................................................................................................. 24
Frontale kwab: dysfuncties ........................................................................................................................... 24
Parietale kwab: dysfuncties .......................................................................................................................... 25
Temporale kwab: dysfuncties ....................................................................................................................... 25
Occipitale kwab: (dys)functies ...................................................................................................................... 25
Hersenstam: (dys)functies ............................................................................................................................ 25
Cerebellum: (dys)functies ............................................................................................................................. 26
Basale ganglia ................................................................................................................................................ 26
De ziekte van parkinson .................................................................................................................................... 27
Pathofysiologie .............................................................................................................................................. 27
Basale ganglia ................................................................................................................................................ 28
Basale ganglia: connectiviteit ........................................................................................................................ 28
Connectiviteit met andere structuren........................................................................................................... 29
Frontostriataal netwerk ................................................................................................................................ 29
Parkinson’s disease PD ...................................................................................................................................... 30
, 3
Klinische manifestaties .................................................................................................................................. 30
Motorische symptomen – rigiditeit .............................................................................................................. 30
Motorische symptomen - bradykinesie ........................................................................................................ 31
Motorische symptomen - Tremor ................................................................................................................. 31
Motorische symptomen - gangstoornissen .................................................................................................. 31
Motorische symptomen - Freezing of gait (FOG) .......................................................................................... 31
Klinische manifestaties .................................................................................................................................. 32
Niet-motorische sytmpomen – depressie ..................................................................................................... 32
Niet-motorische symtpomen - Apathie ........................................................................................................ 32
Niet motorische symptomen - impulsieve en compulsieve gedrgingen ....................................................... 33
Niet motorische symtpomen - executyieve functies .................................................................................... 33
Niet-motorische symptomen - cognitieve beperkingen ............................................................................... 34
Niet-motorische symptomen - dementie...................................................................................................... 34
Parkinsonisme (Parkinson +) ......................................................................................................................... 34
Multiple system atrophy (MSA) ........................................................................................................................ 35
Pathofysiologie .............................................................................................................................................. 35
Klinische Manifestaties ................................................................................................................................. 35
Fenotypes & Klinische Manifestaties ............................................................................................................ 36
Progressive supranuclear palsy ......................................................................................................................... 37
Pathofysiologie .............................................................................................................................................. 37
Fenotypes & Klinische Manifestaties ............................................................................................................ 37
Corticobasal degeneration (CBD) ...................................................................................................................... 38
Pathofysiologie .............................................................................................................................................. 38
Fenotypes & Klinische Manifestaties ............................................................................................................ 39
Lewy body dementia ......................................................................................................................................... 39
Pathofysiologie .............................................................................................................................................. 40
Klinische Manifestaties ................................................................................................................................. 40
Progressie ...................................................................................................................................................... 41
Rol van de psycholoog....................................................................................................................................... 41
Neuropsychologisch onderzoek bij bewegingsstoornissen ........................................................................... 41
Neuropsychologisch onderzoek .................................................................................................................... 42
Neuropsychologische principes bij de revalidatie van bewegingsstoornissen ............................................. 43
Schizofrenie.................................................................................................................................................... 44
Kenmerken ........................................................................................................................................................ 44
Drie types symptomen .................................................................................................................................. 44
Verloop en geslacht....................................................................................................................................... 44
Erfelijkheid ........................................................................................................................................................ 45
, 4
Verwanten ..................................................................................................................................................... 45
Mutaties ........................................................................................................................................................ 45
Leeftijd van de vader ..................................................................................................................................... 46
Omgevingsinvloeden ......................................................................................................................................... 46
Epidemiologie................................................................................................................................................ 46
Rol van stress ................................................................................................................................................ 48
Ontwikkeling ..................................................................................................................................................... 49
Brein .............................................................................................................................................................. 49
Dopaminehypothese ......................................................................................................................................... 51
Pathways ....................................................................................................................................................... 51
Aanwijzingen ................................................................................................................................................. 51
Mesolimbisch systeem: VTA ......................................................................................................................... 52
Tegenargumenten ......................................................................................................................................... 52
Hypofrontaliteit ............................................................................................................................................. 52
Glutamaathypothese .................................................................................................................................... 52
Motoriek en forward models ............................................................................................................................ 53
Corollary discharge........................................................................................................................................ 53
Evolutionaire paradox ....................................................................................................................................... 54
Creativiteit ..................................................................................................................................................... 54
N400 en openheid ......................................................................................................................................... 55
Verslaving ...................................................................................................................................................... 56
Inleiding ............................................................................................................................................................. 56
Definitie ......................................................................................................................................................... 56
Waarom? ....................................................................................................................................................... 56
Beloningssystemen ........................................................................................................................................... 58
Positieve bekrachtiging ................................................................................................................................. 60
Negatieve bekrachtiging ............................................................................................................................... 64
Executieve systemen ......................................................................................................................................... 65
Stress ................................................................................................................................................................. 66
Stressystemen ............................................................................................................................................... 66
Overzicht ........................................................................................................................................................... 68
Non-invasieve hersenstimulatie ..................................................................................................................... 69
Inleiding ............................................................................................................................................................. 69
Non-invasieve hersenstimulatie ........................................................................................................................ 70
Transcranial Magnetic Stimulation (tms) ...................................................................................................... 70
Transcranial Direct Current Stimulation (tDCS)............................................................................................. 71
Transcranial Alternating Current Stimulation (tACS) .................................................................................... 73
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller studentsammie. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $3.23. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67474 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now